Healthcare >> CEO Interviews >> September 14, 2001
JON SYMONDS joined the AstraZeneca Board and Senior Executive Team from
Zeneca, where he had held the position of Finance Director since 1997.
Jon was previously a Partner of KPMG, having joined that company in
1980. During his 17 years with KPMG, Jon worked on a number of major
flotation and investigation projects, and was seconded to the US where
he gained experience of the U.S. market and Securities and Exchange
Commission reporting. He also managed the ICI Group audit from 1987 to
1992 before being seconded to ICI to assist with the demerger project
and the formation of Zeneca, ultimately becoming KPMG's lead partner for
its worldwide services to Zeneca. For the last six years with KPMG, Jon
worked on a number of major transactions, which had a profound impact on
the restructuring of the chemicals and pharmaceuticals industry. Jon's
academic qualifications include a Bachelor of Arts (Business and
Finance) and a Fellowship of the Institute of Chartered Accountants in
England and Wales. He is married with a son and a daughter, and retains
a keen interest in sport, the theatre and reading. Profile
of AstraZeneca?
Mr. Symonds: AstraZeneca today is the fourth largest pharmaceutical
company with sales of about $16
